The shelf activation increases the likelihood of near-term share sales to fund operations. Watch for any ATM takedown announcements, which would signal immediate dilution. The Phase 2 SANRECO readout in August 2026 is the key catalyst; any offering before then may pressure the stock.
Price Chart
Executive Summary
Silence Therapeutics' $300M universal shelf registration (including a $100M ATM facility) became effective on May 27, 2026. The company, with $70.1M in cash and a $15M quarterly net loss, can now sell shares at any time, creating near-term dilution overhang ahead of Phase 2 SANRECO data in August 2026.
Key Facts
- Effectiveness date: May 27, 2026 for shelf registration on Form S-3 (File No. 333-295992).
- Shelf includes up to $300M in securities, with an ATM facility for up to $100M in ADSs via Jefferies.
- Q1 2026 cash and short-term investments: $70.1M; net loss: $15.0M; revenue: $0.4M.
- Phase 2 SANRECO topline data expected August 2026.
Financial Impact
Potential dilution of up to $300M (or $100M through ATM) against current market cap. Exact impact depends on timing and pricing of any takedowns.
Risk Factors
- Dilution from ATM or follow-on offerings under the shelf.
- Cash burn rate may accelerate, forcing earlier or larger offerings.
- Negative Phase 2 data could compound dilution impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001774 |
| Document: 9999999995-26-001774-index.html | 9999999995-26-001774 |
| Document: 9999999995-26-001774.txt | 9999999995-26-001774 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 28, 2026 21w ago | EFFECT | $1.06 $1.06 | · 0.00% | ▲ +0.33% | $6.37 (−500.94%) |
May 27, 2026 21w ago | 424B5 | $1.06 $1.06 | · 0.00% | ▲ +0.33% | $6.37 (−500.94%) |
May 18, 2026 23w ago | S-3 | $1.45 $1.06 | ▲ +27.02% | ▲ +29.32% | $6.37 (−338.55%) |
May 7, 2026 24w ago | 8-K | $2.63 $1.45 | ▼ −44.77% | ▼ −46.28% | $6.37 (+142.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers